DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 -4.66 -0.10%
S&P 500 1,978.91 0.57 0.03%
market minute promo

1.34 -0.02 (-1.47%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NAVB $1.34 -1.47%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.35
Previous Close $1.36
Daily Range $1.33 - $1.36
52-Week Range $1.11 - $3.16
Market Cap $202.0M
P/E Ratio -3.68
Dividend (Yield) $0.00 (0.0%)
Volume 500,956
Average Daily Volume 934,717
Current FY EPS -$0.31

Sector

Healthcare

Industry

Healthcare Information Services

Navidea Biopharmaceuticals, Inc. (NAVB) Description

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. Website: http://www.navidea.com/

News & Commentary Rss Feed

Why Navidea Biopharmaceuticals Inc. Shares Soared

Navidea shares soar after receiving the fast track designation for its lead product. Is now the time to sell or are the good times just getting started?

Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthri

Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthritic Diseases

Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Investor Briefing on Sentinel Lymph Node

Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Investor Briefing on Sentinel Lymph Node Biopsy in Head & Neck Cancers (Transcript)

Accuray Shows Continued Improvement - Analyst Blog

Cyberonics Poised on Favorable Market Trend - Analyst Blog

Thoratec Acquires Irish Implant Systems Maker - Analyst Blog

ABIOMED Acquires Germany's Medical Device Maker - Analyst Blog

Biotech Stock Mailbag: Vanda, Navidea, Provectus

Navidea (NAVB) Worth Watching: Stock Up 7.3% - Tale of the Tape

2 Small Biotech Plays Moving Up On Positive News

UPDATE: Navidea Biopharma Announces Positive Lymphoseek Injection Results

See More NAVB News...

NAVB's Top Competitors

NAVB $1.34 (-1.47%)
Current stock: NAVB
$0.00 (0.00%)
Current stock:
MDT $62.76 (-0.22%)
Current stock: MDT
COV $87.10 (-0.79%)
Current stock: COV